Industry News

Cambrex Corporation announced that second quarter 2016 financial results will be released on Thursday, July 28, 2016 before the market opens. The Company will host a conference call to discuss the financial results. Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics."/>
Cambrex to Announce Second Quarter 2016 Financial Results on July 28, 2016
Merck Announces Fourth-Quarter 2016 Dividend
Baxter's Portfolio Contributed to Growth in Second Quarter. -Second Quarter GAAP Earnings Per Share Were $2.19; Adjusted Earnings Per Share Were $0.46. DEERFIELD, Ill.- Baxter International Inc. today reported results for the second quarter of 2016, and increased its sales and earnings per share outlook for full-year 2016."/>
Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016
Kamada Ltd., a plasma-derived protein therapeutics company focused on orphan indications, announces that it will release financial results for the second quarter ended June 30, 2016 prior to the open of the U.S. financial markets on Tuesday, August 2, 2016.. Kamada management will host an investment community conference call on Tuesday, August 2, 2016 at 8:30 a.m. Eastern time to discuss these results and answer questions."/>
Kamada to Host Second Quarter Financial Results Conference Call on August 2, 2016 at 8:30 am Eastern Time
Quest Diagnostics, the world's leading provider of diagnostic information services. Believed to be the largest ever examination of prescription drug misuse patterns based on physician-ordered laboratory..."/>
One in Two American Adults Misuse Their Prescription Drugs, Finds Analysis of More Than Three Million Lab Tests from Quest Diagnostics
Tokai Pharmaceuticals, Inc. regarding its business and operations complied with federal securities laws. On July 26, 2016, Tokai announced that it was ending a late-stage trial of galeterone, its potential prostate cancer therapy. The Company stated that it did not believe the phase 3 study would meet its primary endpoint."/>
INVESTOR ALERT: Investigation of Tokai Pharmaceuticals Announced by Holzer & Holzer LLC
Sangamo BioSciences, Inc., the leader in therapeutic genome editing, today announced the presentation of preclinical data that supports the clinical development of its new proprietary gene therapy for the treatment of hemophilia A. This new therapeutic comprises an adeno-associated virus cDNA human Factor 8 construct driven by Sangamo's proprietary synthetic liver specific promoter, which in preclinical studies is at least..."/>
Sangamo BioSciences Announces New Gene Therapy Clinical Development Program for Treatment Of Hemophilia A
Canopy Growth Corporation, joined Rob Peterman, Director, Global Business Development, Toronto Stock Exchange& TSX Venture Exchange to open the market. Canopy Growth is a diversified cannabis company, offering brands and curated cannabis strain varieties in dried and oil extract forms. Through its wholly-owned subsidiaries, Tweed, Tweed Farms, and Bedrocan Canada, Canopy Growth operates three production facilities."/>
Canopy Growth Corporation Opens the Market
RadNet, Inc., a national leader in providing high-quality, cost-effective diagnostic imaging services and Medic Vision Imaging Solutions, Ltd., the leading innovator of vendor-independent solutions for low-dose CT exams, announced today that RadNet has selected Medic Vision's SafeCT product suite to enable compliance with low dose CT scanning and XR-29 regulations. RadNet was seeking a solution to comply with..."/>
RadNet, Inc., a national leader in outpatient diagnostic imaging, selects Medic Vision SafeCT solutions for low dose CT scanning and Smart Dose compliance
Inovio Pharmaceuticals, Inc. today announced the dosing of the first subject in its multi-center phase I trial to evaluate Inovio’ s Zika DNA vaccine. In addition to the previously announced US FDA approval for the conduct of the study, Health Canada’ s Health Products and Food Branch has also approved this study, which will be conducted at clinical sites in Miami, Philadelphia, and Quebec City.. This phase I, open-label, dose-ranging study of 40..."/>
Inovio Pharmaceuticals Doses First Subject in Zika Vaccine Clinical Trial
INC Research Holdings, Inc., a leading global Phase I to IV contract research organization, and IAOCR, an internationally recognized accrediting organization for the clinical research industry, today announced INC Research has achieved the“ Bronze Standard” within the IAOCR Clinical Operations Workforce Quality Accreditation program. INC is the first CRO to achieve accreditation under the new program, which is designed to serve as an international..."/>
INC Research Attains Bronze Standard under the IAOCR Clinical Operations Workforce Quality Accreditation Program
Cynosure, Inc., a leading developer and manufacturer of a broad array of light-based aesthetic and medical treatment systems, will visit the Nasdaq MarketSite in Times Square in celebration of the company’ s 25 th anniversary. In honor of the occasion, Michael R. Davin, Chairman, President and CEO, and other members of the management team will ring the Closing Bell. Where: Nasdaq MarketSite– 4 Times Square– 43 rd& Broadway– Broadcast Studio."/>
Cynosure, Inc. (Nasdaq: CYNO) to Ring The Nasdaq Stock Market Closing Bell
Depomed, Inc. with an ownership interest in approximately 9.9% of Depomed's outstanding shares, today announced it has delivered an open letter to Depomed shareholders. The full text of the letter follows:. Starboard Value LP, together with its affiliates and director nominees, currently owns approximately 9.9% of the outstanding shares of Depomed, Inc., making us one of the Company's..."/>
Starboard Delivers Letter To Depomed Shareholders
Liberty Property Trust is under agreement to sell much of its holdings in the Great Valley Corporate Center, the pioneering Chester County business park that transformed Malvern and made the developer into a major regional office landlord. The company is selling 26 Great Valley properties, accounting for more than a million square feet of office and light-industrial space, to Horsham-based Workspace Property Trust, Liberty announced Monday. The properties are part..."/>
Liberty Property Trust to sell most Great Valley Corporate Center holdings in milestone for company [The Philadelphia Inquirer]
Halozyme Therapeutics, Inc. announced today that Eisai Inc. has dosed the first patient in a collaborative phase 1 b/2 clinical trial to assess whether Eisai's eribulin mesylate in combination with Halozyme's investigational drug PEGPH20 can improve overall response rate– the proportion of women that have a predefined reduction in tumor burden– as compared with eribulin alone as a therapy in women with advanced or metastatic,..."/>
Eisai And Halozyme Initiate Phase 1b/2 Clinical Trial With First Patient Dosing Of Eribulin In Combination With PEGPH20
Utah Medical Products, Inc. continued to achieve results which are on track to meet its previously announced goals for 2016.. Currencies in this report are denoted as$ or USD= U.S. Dollars; AUD= Australia Dollars; GBP= UK Pound Sterling; and EUR= Euros."/>
Utah Medical Products, Inc. Reports Financial Performance for Second Quarter 2016
Stereotaxis, Inc., a global leader in innovative technologies for the treatment of cardiac arrhythmias, today announced the market release of its second generation V-CAS Deflect™ catheter advancement system in Europe. The V-CAS Deflect catheter advancement system is designed to remotely control a proprietary robotic deflectable sheath during a cardiac ablation procedure with the Stereotaxis Niobe ® remote magnetic navigation system."/>
Stereotaxis Releases Second Generation V-CAS Deflect™ System in Europe
Oramed Pharmaceuticals Inc., a developer of oral drug delivery systems, announced today the appointment of Dr. Roy Eldor MD PhD to the newly created position of Chief Medical Director."/>
Oramed Appoints Dr. Roy Eldor as Chief Medical Director

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Financials647 Articles
Information Technology603 Articles
Consumer Discretionary563 Articles
Industrials443 Articles
Health Care392 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at